来源: WSJ Markets ↗
Trump Administration Shift Puts This Corner of Biotech Back in Favor
|
暂时无法翻译，请重试。
来源报道重点
With the Food and Drug Administration’s hard-liners gone, investors are rushing back into rare-disease bets.
在 WSJ Markets 阅读原始报道 ↗